1. X
  2. Bio Protocol
Log inSign up
Bio Protocol
10.3K posts
Image
user avatar
Bio Protocol
@BioProtocol
Biotech's new financial layer.
app.bio.xyz
Joined May 2022
291
Following
115.8K
Followers
AffiliatesAffiliatesRepliesRepliesMediaMedia

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • Pinned
    user avatar
    Bio Protocol
    @BioProtocol
    Jul 6
    June in the Biosphere 🌐 • The first wet-lab resulsts for @peptai_ are in. AI-designed binders against a cancer target, tested and already feeding the next round. • BIOS ( @BioAIDevs) can now take a protein target to ranked drug candidates in under an hour, for under $7. •
    user avatar
    Bio Protocol
    @BioProtocol
    Jul 6
    Article cover image
    Article
    Bio Monthly (June 2026): DeSci Berlin, OpenLabs, PeptAI's First Wet-Lab Results
    Highlights from June in the Biosphere 🌐 For a hundred years, getting cured meant waiting on an institution. Now the patient is the principal investigator. A founder built a cancer vaccine for his...
    23K
  • Bio Protocol reposted
    user avatar
    BIOS
    Bio Protocol
    @BioAIDevs
    5h
    BIOS ranks every drug candidate using a scoring metric validated against 3,766 real lab experiments. Every cutoff is calibrated from actual binding data, so when BIOS tells you a design is promising, that confidence traces back to physical results.
    Image
    00:00
    904
  • Bio Protocol reposted
    user avatar
    PeptAI
    Bio Protocol
    @peptai_
    6h
    Anyone can now rent the models that design a drug candidate. Almost no one can rent the experimental record that proves which candidates are real. Why models are commoditizing, what drug failure actually costs, and how PeptAI turns every run into a compounding dataset 🧵
    Image
    00:00
    5.5K
  • user avatar
    Bio Protocol
    @BioProtocol
    Jul 12
    "Yes, you should lose weight and exercise but let's cut to the chase...you should be on GLP." We sat down with Dr. Mohsen Soofian, a board-certified physician who has used peptides in clinical practice for nearly a decade. Here is what actually holds up. 🧵
    Image
    00:00
    8.9K
    user avatar
    Bio Protocol
    @BioProtocol
    Jul 12
    Replying to @BioProtocol
    Two areas patients ask about most: brain and sleep. For cognition, Dihexa works through the HGF pathway and drove a large jump in synaptic connections in mice. People report feeling sharper and more engaged. Because it is strongly growth-promoting, he limits it to one to two
    Image
    00:00
    1.1K
    user avatar
    Bio Protocol
    @BioProtocol
    Jul 12
    The honest part: the evidence is still thin. Most protocols are extrapolated from animal models. What the field needs is large, randomized, double-blind human trials, the same bar pharmaceuticals clear. GLP-1s show what happens when that work gets done. If you are curious, his
    1.5K
  • user avatar
    Bio Protocol
    @BioProtocol
    Jul 10
    Replying to @BioProtocol
    DeSciNYC: Peptides 101, Tuesday July 14:
    Image
    DeSciNYC: Peptides 101 · Luma
    From luma.com
    1.2K
  • user avatar
    Bio Protocol
    @BioProtocol
    Jul 10
    Replying to @BioProtocol
    Catalyst NYC, tomorrow July 11:
    Image
    Catalyst NYC: The Future of Translational Science · Luma
    From luma.com
    2.2K
  • user avatar
    Bio Protocol
    @BioProtocol
    Jul 10
    The Bio community is on the ground in New York this month. Two stops: Catalyst NYC by @ResearchHub (translational science, funding models, open science infra) and DeSciNYC's Peptides 101 session. If you're building in material science, enzyme engineering, microbial strain
    Image
    00:00
    9.2K
  • user avatar
    Bio Protocol
    @BioProtocol
    Jul 10
    OpenLabs started with a simple idea. Put the scientific method in the open, so humans and AI agents can post, challenge and develop hypotheses together. The question now is what runs on top of it. The answer, so far, is three flagship projects: a rheumatology pharmacogenomics
    Image
    00:00
    8.4K
    user avatar
    Bio Protocol
    @BioProtocol
    Jul 10
    Replying to @BioProtocol
    Radicular: Non-Sedating Peptide Analgesics, built with @PeptAI Lumbosacral radiculopathy, the nerve pain that runs from the lower back down the leg, is usually managed with gabapentinoids that leave patients sedated. Radicular develops drug-like peptide analogs of a published
    Image
    1K
    user avatar
    Bio Protocol
    @BioProtocol
    Jul 10
    All three are live on OpenLabs. Read the hypotheses, follow the agent reviews, and back the projects worth testing. Sign up now: openlabs.bio.xyz/signup
    945
  • Bio Protocol reposted
    user avatar
    Bio Protocol
    @BioProtocol
    Jul 8
    He sold his last cancer company to Eli Lilly for $300M. His next one isn't going the traditional route. Here's the case for DeSci from someone who already won the old game 🧵
    Image
    00:00
    12K
  • Bio Protocol reposted
    user avatar
    PeptAI
    Bio Protocol
    @peptai_
    Jul 8
    AI can design a thousand proteins in an hour. It still cannot reliably predict which ones work, because biology never generated the data that teaches a model to generalize. A thread on the real constraint in AI drug discovery 🧵
    Image
    00:00
    2.5K
Advertisement
Advertisement